Navigation Links
ARIUS announces second quarter fiscal 2008 financial results
Date:7/11/2008

ly, ARIUS has antibody programs targeting the MCSP antigen and

37LRP, in addition to several other undisclosed programs.

- ARIUS now has 26 issued or allowed patents covering its antibody

programs and discovery platform and over 273 patents pending

worldwide.

Corporate Updates

- Dr. Young was awarded "Most Innovative" award by the Association of

Chinese Canadian Entrepreneurs for demonstration of exceptional

innovation in his field and contribution to the marketplace.

- Secured a sponsored research agreement with the University of Toronto

Health Network and cancer stem cell pioneer, Dr. John E. Dick. In

collaboration with Dr. Dick, ARIUS is assessing the impact of certain

antibodies on cancer stem cells.

- Continued to evaluate its strategic options with global

pharmaceutical and biotechnology companies.

Financial Results:

All amounts are in Canadian dollars unless otherwise indicated.

For the six-month period ended May 31, 2008, the Company recorded a net loss of $6,401,018 ($0.14 per share) compared to a net loss of $5,342,827 ($0.12 per share) for the six-month period ended May 31, 2007. For the three-month period ended May 31, 2008, the Company recorded a net loss of $3,816,937 ($0.08 per share) compared to a net loss of $3,036,132 ($0.07 per share) for the three-month period ended May 31, 2007. This increase in net loss for both periods is primarily the result of higher research and development, and general administrative expenses, partially offset by higher revenues and foreign exchange gains.

For the six-month period ended May 31, 2008, the Company's revenue increased to $1,471,447 compared to $129,846 for the same period in fiscal 2007. For the three-month period ended May 31, 2008, the Company's revenue increased to $424,153 compared to $21,392 for the same period in fiscal 2007. The increase for both pe
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ARIUS presents new findings for anti-cancer antibody programs at AACR
2. ARIUS announces first quarter fiscal 2008 financial results
3. ARIUS 2008 Annual and Special Meeting of Shareholders
4. ARIUS recognized for entrepreneurial excellence
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
7. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
8. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
9. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... PHILADELPHIA , July 1, 2015 ... technology will ... s evidence-based clinical s olutions suite ... scientific, technical and medical information products and services, announced today ... -based clinical decision support (CDS) technology company. InferMed,s ...
(Date:7/1/2015)... , July 1, 2015  UCB, a ... ), a global leader in designing, transforming, and ... Innovation Award in recognition of their close collaboration ... in UCB,s global business services (GBS) finance organization. ... providers and clients that work together effectively to ...
(Date:6/30/2015)... - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that ... approved the resolutions relating to: (i) a private ... at a price of $2.67 per unit (the ... one common share and 0.075358 common share purchase ... and (ii) the amendment to Resverlogix,s articles to ...
(Date:6/30/2015)... June 30, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... developing therapeutics that address unmet medical needs in ... Elston will present at the Cantor Fitzgerald ... 8, 2015Time: , 4:45 PM EDTLocation: , Le ... archive): , www.juniperpharma.com, under  ,Investor, or  ...
Breaking Biology Technology:Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2
... convergence on Thursday at the Consumer Electronics Show in Las ... , ,Designed as part of the companys plan to unite ... recording and Internet service in a set-top box. The system ... ,In his keynote address, SBC chairman Edward Whitacre said bringing ...
... Kendrick, a mechanical engineer for the department of physics, ... the Madison Dynamo Experiment at a remote UW-Madison physics ... underground bunker that brushes up against a Wisconsin barnyard ... a team of scientists, using a molten ball of ...
... truly protected global trademark is worth a ton in gold. ... iconic personality with a top-level protection plan and equipped with ... face it; such a name is worth a hundred times ... factories and all the stacking chimneys combined. Just ask Sony, ...
Cached Biology Technology:SBC blends TV, video, music and the Internet in a new media box 2Earth's core modeled in underground experiment 2Earth's core modeled in underground experiment 3Global branding is easy with global trademarks 2Global branding is easy with global trademarks 3Global branding is easy with global trademarks 4
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/25/2015)... 2015 According to a ... & Area), Technology, Material (Optical Prism, Piezoelectric, Capacitive ... & Others) & Geography - Global Forecast to ... market is expected to reach $14,500.07 Million by ... Browse 76 market Tables and 109 Figures ...
(Date:6/24/2015)... NEW YORK , June 24, 2015 ... favorable rate. The major drivers for the market include ... increasing number of new drug launches. Over the years, ... has increased. Between 2001 and 2010, the FDA approved ... addition, according to WIPO, Europe ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... work and scientific adventure, marine explorers from more than ... Laboratory (MBL), today delivered the first global Census of ... and hides in the world,s oceans. In one of ... scientists spent over 9,000 days at sea on more ...
... survived for more than 400 million years, the horseshoe ... overharvest and habitat destruction. However, climatic changes may,also play ... how sensitive horseshoe crab populations are to natural climate ... Molecular Ecology . The horseshoe crab is ...
... Jerusalem, October 4, 2010 Researchers at the Hebrew University ... body that play a key role in controlling bone density, ... drug for prevention and treatment of osteoporosis and other bone ... researchers have just been published in the American journal ...
Cached Biology News:MBL scientists reveal findings of World Ocean Microbe Census 2MBL scientists reveal findings of World Ocean Microbe Census 3Climate change affects horseshoe crab numbers 2Hebrew University research holds promise for development of new osteoporosis drug 2
Request Info...
... Sepharose 4B, 10 ... purification of calmodulin-binding ... of calmodulin-regulated proteins ... cells. Category: Chromatography ...
...
AdestaTM Tissue/Cell Preservation Medium Sterile / Non-sterile: Sterility Tested Endotoxin: ...
Biology Products: